CGA - January 2009
Generic Medication Substitution Required

Effective April 1, substituting generic equivalent drugs when filling prescriptions will be required and will apply to the following products:

  • BlueScript® (BlueOptions® and BlueChoice® health plans)
  • MediScript (BlueChoice health plans)
  • BlueCare RxSM (BlueCare® HMO plans).

If a member chooses a brand drug when a generic equivalent is available, they will be responsible for paying the cost difference as well as their copayment difference (not to exceed the cost of the medication). Mandatory generic substitution does not apply if the prescriber requests the brand drug. In order for the member to fill the brand-name prescription without paying the cost difference the prescribing physician must indicate "Medically Necessary" on the prescription.

Mandatory Generic Substitution is a standard benefit for all new groups sold with an April 1, 2009 effective date or thereafter. Group business renewals will start adding this enhancement with April 1, 2009 renewals and forward. Pharmacy endorsements will be mailed to members starting this month.

More than 94% of our members already use generic equivalents. This change allows us to reduce benefit costs and help our pharmacy products remain competitive. Our goal is to continue to provide Floridians with affordable health care choices and to address the increasing costs of health care coverage.


For questions about programs, products or services, please contact our Agent Service Center
at 800-267-3156, or your local Blue Cross and Blue Shield of Florida sales representative.

QuickLinks
Feedback
BCBSFLinks
Resources